Serological response after COVID-19 mRNA-1273 booster dose in immunocompromised patients, Taiwan, July to August 2021
Journal
Journal of the Formosan Medical Association = Taiwan yi zhi
Date Issued
2022-08-31
Author(s)
Ieong, Si-Man
Cheng, Chien-Yu
Abstract
Whether immunocompromising conditions affect the immunogenicity of COVID-19 booster vaccination remains a concern, which impedes the vaccination campaign in people most vulnerable to COVID-19-associated morbidity and mortality. We aimed to evaluate the effect of immune dysfunction on immunogenicity of homologous and heterologous prime-boost COVID-19 vaccination.
Subjects
Autoimmune disease; Immunocompromised; Non-steroidal anti-inflammatory drug; Serologic response; mRNA vaccine
SDGs
Type
journal article